Results 141 to 150 of about 50,453 (194)
Prevalence and Risk Factors for Oropharyngeal, Esophageal, and Oral Candidiasis in HIV-Positive Individuals: A Systematic Review and Meta-Analysis. [PDF]
Tan XT +3 more
europepmc +1 more source
From Denial to Near Blindness: Overcoming Herpes Zoster Ophthalmicus in a Rural Ugandan Man with HIV and Alcoholism. [PDF]
Okongo B +4 more
europepmc +1 more source
Dangerous liaisons: Candidalysin and myeloid cells in candidiasis. [PDF]
Gu ZQ, Chen YY, Tsai YH.
europepmc +1 more source
HIV, HPV, and oral health in Tanzania: a scoping review. [PDF]
Gedion K +10 more
europepmc +1 more source
Prophylaxis of oropharyngeal candidiasis with clotrimazole.
A total of 202 evaluable cancer patients were randomly assigned to receive or not receive oral clotrimazole as antifungal prophylaxis during hospitalization. Oropharyngeal candidiasis occurred in 1% of the former patients and 27% of the latter patients (P less than .00001).
E, Yeo +3 more
openaire +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Prophylaxis of Oropharyngeal Candidiasis with Fluconazole
Clinical Infectious Diseases, 1990A total of 112 cancer patients who could ultimately be evaluated were randomly assigned in a double-blind study to receive either fluconazole or placebo as antifungal prophylaxis during hospitalization. Thrush, defined by appropriate lesions in the oropharynx and confirmed by scrapings and cultures positive for Candida species, occurred in 2% of the 58
G, Samonis +4 more
openaire +2 more sources

